Position in GYRE
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$3,512
-$203 QoQ
Shares Held
533
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 60 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GYRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Activest Wealth Management holds $750,609 across 68 Biotechnology names. GYRE ranks #26 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | QURE |
uniQure N.V.
|
5,000 | $230,300 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
1,511 | $58,944 | |
| 3 | AUPH |
Aurinia Pharmaceuticals Inc.
|
3,000 | $50,910 | |
| 4 | CAPR |
Capricor Therapeutics, Inc.
|
2,000 | $48,160 | |
| 5 | KOD |
Kodiak Sciences Inc.
|
1,001 | $38,998 | |
| 6 | URGN |
UroGen Pharma Ltd.
|
1,001 | $36,836 | |
| 7 | ALDX |
Aldeyra Therapeutics, Inc.
|
15,000 | $31,950 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58 | $28,810 |
All Filings in GYRE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,512 | 533 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $3,715 | 533 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $3,762 | 533 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $3,976 | 533 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $3,917 | 533 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $4,114 | 533 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,449 | 533 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $6,683 | 533 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $6,358 | 533 | Shares | Sole | 2024-07-30 | |
| No filing history on record for this holder in this stock. | ||||||